Abstract
A large series of cyclooxygenase-2 (COX-2) inhibitors with diverse skeletons were investigated by means of the Electronic-Topological Method. A system for the COX-2 inhibitor activity prognostication was built with 6 pharmacophores and 6 anti-pharmacophores. The forecasting ability of the system was also tested on different structures, which differ from those that characterize the series studied.
Keywords: cox-2, nsaids, structure-activity relationships (sar)
Mini-Reviews in Medicinal Chemistry
Title: Electronic-Topological Study of Structurally Diverse Cyclooxygenase-2 Inhibitors
Volume: 3 Issue: 4
Author(s): A. Dimoglo, E. Sim, N. Shvets and V. Ahsen
Affiliation:
Keywords: cox-2, nsaids, structure-activity relationships (sar)
Abstract: A large series of cyclooxygenase-2 (COX-2) inhibitors with diverse skeletons were investigated by means of the Electronic-Topological Method. A system for the COX-2 inhibitor activity prognostication was built with 6 pharmacophores and 6 anti-pharmacophores. The forecasting ability of the system was also tested on different structures, which differ from those that characterize the series studied.
Export Options
About this article
Cite this article as:
Dimoglo A., Sim E., Shvets N. and Ahsen V., Electronic-Topological Study of Structurally Diverse Cyclooxygenase-2 Inhibitors, Mini-Reviews in Medicinal Chemistry 2003; 3 (4) . https://dx.doi.org/10.2174/1389557033488060
DOI https://dx.doi.org/10.2174/1389557033488060 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Roles of Perilipins in Diseases and Cancers
Current Genomics MicroRNAs Determining Inflammation as Novel Biomarkers and Potential Therapeutic Targets
Current Medicinal Chemistry Renal Allograft Thrombosis
Current Pediatric Reviews Vitamin D and Vascular Disease
Current Vascular Pharmacology Plasma Ghrelin Levels in Patients with Familial Mediterranean Fever
Protein & Peptide Letters MicroRNAs in Arterial Remodelling, Inflammation and Atherosclerosis
Current Drug Targets Inhibitors of Aldo-Keto Reductases AKR1C1-AKR1C4
Current Medicinal Chemistry Antimicrobial Peptides in Burns and Wounds
Current Protein & Peptide Science Voltage Gated Calcium Channels as Targets for Analgesics
Current Topics in Medicinal Chemistry Piperidin-4-one: The Potential Pharmacophore
Mini-Reviews in Medicinal Chemistry Luteolin, a Flavonoid with Potential for Cancer Prevention and Therapy
Current Cancer Drug Targets Phosphotyrosine Phosphatases in Cancer Diagnostic and Treatment
Recent Patents on DNA & Gene Sequences Erratum
Current Pharmaceutical Design T Cell Polarization and the Formation of Immunological Synapses: From Antigen Recognition to Virus Spread
Current Immunology Reviews (Discontinued) Effect of Conjugated Linoleic Acid Supplementation on Serum Leptin Concentration: A Systematic Review and Meta-Analysis
Endocrine, Metabolic & Immune Disorders - Drug Targets Genetics and Molecular Biology of Tuberous Sclerosis Complex
Current Genomics Probiotics: From Functional Foods to Pharmaceutical Products
Current Pharmaceutical Biotechnology Cardiac Dysfunction in Rats with Dietary-Induced Insulin Resistance Associated with Pharmacologically-induced Dyslipidemia
Current Pharmaceutical Design Hepatitis B and Liver Transplantation
Current Drug Therapy The Drug Targets and Antiviral Molecules for Treatment of Ebola Virus Infection
Current Topics in Medicinal Chemistry